Thus, future experiments are required to study the cellular pathway that controls secretion of gal-1 in the blood stream or the potential function of circulating gal-1 which may represent an additional avenue for treatment of human patients with lung cancers. The gene discussed is LGALS1; the disease is lung carcinoma.